Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer

Veltri Robert W.

首页> 外文期刊>BJU international >Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer

【24h】

Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer

机译：血清标志物％[-2] proPSA和前列腺健康指数提高了临床相关前列腺癌的诊断准确性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《BJU international》 |2016年第1期|共2页
作者
Veltri Robert W.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer [J] . Veltri Robert W. BJU international . 2016,第1期

机译：血清标志物％[-2] proPSA和前列腺健康指数提高了临床相关前列腺癌的诊断准确性
2. Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: Results from a multicentre European study, the PROMEtheuS project [J] . LazzeriM., HaeseA., AbrateA., BJU international . 2013,第3期

机译：血清前列腺特异性抗原同工型[-2] proPSA（p2PSA）及其衍生物％p2PSA和前列腺健康指数（PHI）在有前列腺癌家族史的男性中的临床表现：一项欧洲多中心研究的结果PROMEtheuS项目
3. ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program. [J] . Isharwal S, Makarov DV, Sokoll LJ, Urology . 2011,第3期

机译：ProPSA和诊断性活检组织DNA含量的组合提高了准确性，从而可以预测参加主动监测计划的男性中需要进行前列腺癌治疗的人数。
4. Significance of the −2propsa index and the prostate health index in patients with prostate cancer: A literature review and data of the Russian prospective study [C] . K. B. Kolontarev, D. Yu. Pushkar, A. V. Govorov, Proceedings of the 2017 International Conference "Quality Management, Transport and Information Security, Information Technologies" . 2017

机译：−2propsa指数和前列腺健康指数在前列腺癌患者中的意义：一项俄罗斯前瞻性研究的文献综述和数据
5. MicroRNAs as Zinc Regulators in Cancer Cells and as Serum Markers of Aggressive Prostate Cancer. [D] . Mihelich, Brittany. 2014

机译：MicroRNA作为癌细胞中的锌调节剂和侵略性前列腺癌的血清标志物。
6. ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program [O] . Sumit Isharwal, Danil V. Makarov, Lori J. Sokoll, -1

机译：propsa和诊断活检组织DNa含量的组合提高了精度在主动监测计划以预测极品治疗前列腺癌是男性已登记
7. Editorial comment on: Measurement of serum isoform –2proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2–10 ng/ml [O] . Alberto Abrate, Alchiede Simonato 2017

机译：编辑评论：血清同种型的测量-2 ProCSA衍生物对患者诊断前列腺特异性抗原水平2-10 ng / ml的患者前列腺癌的磁共振成像进行了卓越的准确性
8. Molecular Determinants of Prostate Cancer Progression Across Race- Ethnicity. Project A - The Human 5RD5A2 Gene and Prostate Cancer Progression. Project B - Androgen Receptor (AR) Signaling in Prostate Cancer Progression. Project C - Cellular and Molecular Markers of Prostate Cancer Progression Core - Epidemiology Core [R] . Ross, R. R. , Reichardt, J. , Coetzee, G. A. , 2002

机译：跨越种族的前列腺癌进展的分子决定因素。项目a - 人类5RD5a2基因和前列腺癌进展。项目B - 雄激素受体（aR）在前列腺癌进展中的信号传导。项目C - 前列腺癌进展核心的细胞和分子标记 - 流行病学核心

Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer

著录项

相似文献

相关主题

期刊订阅